# Axceso Biopharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/axceso-biopharma

- Industry: Biotechnology
- Headquarters: Anyang, South Korea
- Website: www.axcesobiopharma.com
- Total disclosed funding: $5.1M
- Latest round: Series A (Sep 1, 2021)
- Investors on record: 5

## About

Based in Anyang, South Korea, and founded in 2010, Axceso Biopharma specializes in the development of biopharmaceuticals and a second research center that develops effective therapeutic substances through chemical synthesis. Founded as Phytos Co., Ltd, the company established a subsidiary, Phytopecia Co., Ltd., and adopted PHYTOPECIA Hair Tonic as a treatment material for Seoul Asan Hospital in 2011. In 2018, the company changed its name to Axceso Biopharma and signed a research contract with the Korea Biotechnology Research Institute for the development of low-molecular-weight immuno-oncology drugs. The company expanded and relocated its first affiliated research institute followed by the establishment of the second corporate research institute for organic synthesis research in Yongin, Gyeonggi-do in 2019.

The company develops and manufactures drugs for the treatment of cancer, neurological diseases, blood infections, diabetes, and Alzheimer's disease.

## Funding rounds

- Series A, Sep 1, 2021, $5.1M — Korea Investment Partners, Shinhan Capital, ES Investor, AG Investment, Time Folio Asset Management

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series A
- ES Investor (https://capitalatlas.ai/funds/es-investor) — Series A
- AG Investment (https://capitalatlas.ai/funds/ag-investment) — Series A
- Time Folio Asset Management — Series A